Company Filing History:
Years Active: 2016
Title: Khaled Benkali: Innovator in Dermatological Treatments
Introduction
Khaled Benkali is a notable inventor based in Antibes, France. He has made significant contributions to the field of dermatology, particularly in the treatment of rosacea. His innovative approach has led to the development of effective methods for managing inflammatory lesions associated with this condition.
Latest Patents
Khaled Benkali holds 1 patent for his work titled "Treatment of inflammatory lesions of rosacea with ivermectin." This patent describes methods for safe and effective treatment of inflammatory lesions of rosacea in a subject. The methods involve once daily topical application to an affected skin area using a composition that contains ivermectin and a pharmaceutically acceptable carrier. His research has demonstrated that once daily topical treatment with ivermectin is significantly superior to twice-daily treatment with metronidazole in reducing inflammatory lesion counts.
Career Highlights
Khaled Benkali is associated with Galderma S.A., a company renowned for its focus on dermatological products. His work at Galderma has allowed him to contribute to advancements in skin health and treatment options for patients suffering from rosacea.
Collaborations
Khaled has collaborated with notable colleagues, including Jean Jacovella and Jean-Paul Chappuis. These collaborations have further enriched his research and development efforts in dermatology.
Conclusion
Khaled Benkali's innovative work in the treatment of rosacea exemplifies the impact of targeted research in dermatology. His contributions continue to enhance the quality of care for patients dealing with this challenging condition.